Arbutus alleges that Moderna’s COVID-19 vaccine infringes on patents protecting its lipid nanoparticle delivery technology.
A federal judge in Delaware has thrown out two key defenses Moderna (MRNA) had been claiming in its ongoing patent litigation with Arbutus Biopharma (ABUS) regarding its mRNA COVID-19 vaccine. Judge ...
The current reality is one of verified, world-class innovation that positions Uganda as a hub for advanced biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results